Artivion Investor Relations Material
Latest events
Q3 2024
Artivion
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Artivion Inc
Access all reports
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues. It offers tissue valves, which are used to replace a patient’s diseased heart valve with a functioning mechanical or biologic tissue valve, as well as performs contract manufacturing activities to develop and manufacture specialty products for other companies. The company was founded in 2012 and is based in New York, New York.
Key slides for Artivion Inc
Q1 2024
Artivion Inc
Investor Presentation
Artivion Inc
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
AORT
Country
🇺🇸 United States